RevBio, Inc.: RevBio Receives Approval to Start a Dental Clinical Trial in Italy for its Regenerative Biomaterial
This Study Will Help Assess the Time Necessary for Tetranite to Regenerate Bone in the Oral Environment RevBio, Inc., announced that it has received approval from the Italian Ministry of Health and
United States Revbio Tetranite Dannunzio Chieti Pescara Gianmaria Daddazio Maurizio Piattelli Manlio Santilli
Source: finanznachrichten.de